Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Brain : a Journal of Neurology
|
September 19, 2015
Strategy and suppression impairments after right lateral prefrontal and orbito-frontal lesions
Lisa Cipolotti, Colm Healy, Barbara Spanò, et al.
Cancer
|
August 1, 2006
Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy
Giuliana Alimena, Massimo Breccia, Roberto Latagliata, et al.
Bioinorganic Chemistry and Applications
|
February 22, 2022
Enhanced Bioactivity of Pomegranate Peel Extract following Controlled Release from CaCO<sub>3</sub> Nanocrystals
Francesca Baldassarre, Viviana Vergaro, Federica De Castro, et al.
Neuropsychologia
|
November 7, 2016
Inhibition processes are dissociable and lateralized in human prefrontal cortex
Lisa Cipolotti, Barbara Spanò, Colm Healy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Brain-age in ultra-low-field MRI: how well does it work?
Francesca Biondo, Carly Bennallick, Sophie A Martin, et al.
Blood Advances
|
February 24, 2026
Safety, efficacy and patient-reported outcomes 6 years after fidanacogene elaparvovec in adults with hemophilia B
Benjamin J Samelson-Jones, John Ej Rasko, Jonathan Ducore, et al.
International Journal of Hematology
|
August 25, 2009
Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results
Roberto Latagliata, Angela Rago, Antonio Spadea, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 19, 2025
Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial
Kaan Kavakli, Adam Cuker, Laurent Frenzel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 20, 2025
Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study
Davide Matino, Laurent Frenzel, Ali Bulent Antmen, et al.
The New England Journal of Medicine
|
September 25, 2024
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B
Adam Cuker, Kaan Kavakli, Laurent Frenzel, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Brain : a Journal of Neurology
|
September 19, 2015
Strategy and suppression impairments after right lateral prefrontal and orbito-frontal lesions
Lisa Cipolotti, Colm Healy, Barbara Spanò, et al.
Cancer
|
August 1, 2006
Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy
Giuliana Alimena, Massimo Breccia, Roberto Latagliata, et al.
Bioinorganic Chemistry and Applications
|
February 22, 2022
Enhanced Bioactivity of Pomegranate Peel Extract following Controlled Release from CaCO<sub>3</sub> Nanocrystals
Francesca Baldassarre, Viviana Vergaro, Federica De Castro, et al.
Neuropsychologia
|
November 7, 2016
Inhibition processes are dissociable and lateralized in human prefrontal cortex
Lisa Cipolotti, Barbara Spanò, Colm Healy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Brain-age in ultra-low-field MRI: how well does it work?
Francesca Biondo, Carly Bennallick, Sophie A Martin, et al.
Blood Advances
|
February 24, 2026
Safety, efficacy and patient-reported outcomes 6 years after fidanacogene elaparvovec in adults with hemophilia B
Benjamin J Samelson-Jones, John Ej Rasko, Jonathan Ducore, et al.
International Journal of Hematology
|
August 25, 2009
Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results
Roberto Latagliata, Angela Rago, Antonio Spadea, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 19, 2025
Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial
Kaan Kavakli, Adam Cuker, Laurent Frenzel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 20, 2025
Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study
Davide Matino, Laurent Frenzel, Ali Bulent Antmen, et al.
The New England Journal of Medicine
|
September 25, 2024
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B
Adam Cuker, Kaan Kavakli, Laurent Frenzel, et al.
Page
of 4